View all cases
UPC APP 32590/2025
- Case details
- Status—ActionProcedural applicationCategoryConfidentiality (RoP 262A / 262.2)
- Parties
- Respondents
- Moderna, Inc.Operating co.
- Moderna Belgium S.R.L.Operating co.
- Moderna Denmark ApSOperating co.
- Moderna Sweden ABOperating co.
- Moderna Switzerland GmbHOperating co.
- Moderna Portugal Unipessoal LDAOperating co.
- ModernaTX, Inc.Operating co.
- Moderna Norway ASOperating co.
- Moderna Poland Sp. z o.o.Operating co.
- Moderna Netherlands B.V.Operating co.
- Moderna Biotech UK LimitedOperating co.
- Moderna Italy S.R.L.Operating co.
- Moderna Germany GmbHOperating co.
- Moderna France SASUOperating co.
- Moderna Biotech Spain SLOperating co.
Representatives- Ruben Laddé
- Joachim Renken
- Division
- The Hague LD
- Judges
- —
- Language
- —
- First decided
- Aug 4, 2025
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| The Hague LD | Locked |
At the UPC: Arbutus Biopharma Corporation (12 cases)·Moderna Group (20 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
Decisions
- 2025-08-04Application RoP262APublic
Summary: The Local Division The Hague issued a confidentiality order under R.262A RoP based on an agreement reached between Moderna entities and Arbutus Biopharma/Genevant, establishing a confidentiality club for technical information disclosed in infringement proceedings concerning mRNA vaccine patents.
Show the legal issues (3)
- Confidentiality order (R.262A RoP)
- Confidentiality club
- Protection of trade secrets in patent proceedings
Documents
- 46231E94C779CBF934A0E5BE534B0AFA_en.pdf2025-08-04EN